Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.56 |
| ▸ | CA1 | P00915 | 13/20 | 0.56 |
| ▸ | CA9 | Q16790 | 12/20 | 0.56 |
| ▸ | CA12 | O43570 | 8/20 | 0.56 |
| ▸ | CA6 | P23280 | 3/20 | 0.56 |
| ▸ | CA5A | P35218 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.56 |
| ▸ | CA3 | P07451 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12325098 | 0.91 | ALDH1A1 (0.55) | CA2CA1CA9CA12CA6 | |
| SCHEMBL4807069 | 0.84 | CA2 (0.50) | CA2CA1CA9CA12CA6 | |
| Sulfamide SCHEMBL29026073 | 0.82 | ALDH1A1 (0.55) | CA2CA1CA9CA12CA6 | |
| SCHEMBL23792366 | 0.80 | CA2 (0.43) | CA2CA1CA9CA12CA6 | |
| SCHEMBL25094400 | 0.80 | KDM4E (0.45) | CA2CA1CA9CA12CA6 | |
| Methanesulfonamide SCHEMBL4804491 | 0.79 | CA1 (0.53) | CA2CA1CA9CA12CA6 | |
| Methanesulfonamide SCHEMBL4804172 | 0.79 | CA1 (0.53) | CA2CA1CA9CA12CA6 | |
| SCHEMBL11178716 | 0.79 | CA2 (0.44) | CA2CA1CA9CA12CA6 | |
| SCHEMBL11176657 | 0.79 | TPMT (0.59) | CA2CA1CA9CA12CA6 | |
| SCHEMBL1171992 | 0.79 | CA1 (0.52) | CA2CA1CA9CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119219810-A | Ionic polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119219810-A | Ionic polymer and preparation method and application thereof | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119219809-A | Fluorine-containing polymer, preparation method thereof and ion exchange membrane | 佛山绿动氢能科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-110139854-A | O- substituted isohydroxyloxime acid | 约翰斯霍普金斯大学 | 2019-08-16 | — | — | CN | disclosed |
| CN-107922371-A | Hydroxamic acid of the substitutions of the N with carbon-based leaving group as effective HNO donors and application thereof | 约翰斯霍普金斯大学 | 2018-04-17 | — | — | CN | disclosed |
| CN-103664974-B | Aryl [a] indole [2,3-g] quinolizine compounds, its preparation method, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2016-12-21 | — | — | CN | disclosed |
| CN-102388112-B | Photocatalyst coating material, photocatalyst coating film, and layered coating film structure | METAL-TECH LTD. (JP) | 2015-08-19 | — | — | CN | disclosed |
| US-20150093692-A1 | PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM USED THEREFOR, AND ELECTRONIC DEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAMEDEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2015-04-02 | — | — | US | disclosed |
| CN-103664974-A | Aryl [a] indole [2,3-g] quinolizine compound as well as preparation method, pharmaceutical composition and application thereof | SHANGHAI INST MATERIA MEDICA | 2014-03-26 | — | — | CN | disclosed |
| CN-101709045-B | Preparation method of thiophenol | UNIV ZHEJIANG | 2013-02-27 | — | — | CN | disclosed |
| US-7964633-B2 | such as N,N'-[hexane-1,6-diylbis(iminocarbonyl)]bis(3-chlorobenzenesulfonamide), used as Fructose-1,6-bisphosphatase inhibitors; metabolic disorders such as diabetes | HOFFMANN-LA ROCHE INC. (US) | 2011-06-21 | — | — | US | disclosed |
| EP-2081889-B1 | SULFONAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-12-22 | — | — | EP | disclosed |
| CN-101709045-A | Preparation method of thiophenol | UNIV ZHEJIANG | 2010-05-19 | — | — | CN | disclosed |
| EP-2081889-A1 | SULFONAMIDE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2009-07-29 | — | — | EP | disclosed |
| US-20080085928-A1 | Sulfonamide derivatives | HOFFMANN-LA ROCHE INC. | 2008-04-10 | — | — | US | disclosed |
| WO-2008037628-A1 | SULFONAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2008-04-03 | — | — | WO | disclosed |
| US-20060004010-A1 | Ccr4 antagonist and medical use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-1541563-A1 | CCR4 ANTAGONIST AND MEDICINAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-06-15 | — | — | EP | disclosed |
| CN-1133703-C | Latex outer wall paint and its preparation process | 华南理工大学 | 2004-01-07 | — | — | CN | disclosed |
| CN-1308103-A | Latex outer wall paint and its preparation process | HUANAN SCIENCE & ENGINEERING (CN) | 2001-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004010-A1 | Ccr4 antagonist and medical use thereof | CCR4, CCR1, CCR9 | CA2 743/4885CA1 838/4885CA9 495/4885 |
| US-20080085928-A1 | Sulfonamide derivatives | SULT2A1, SULT1A1, SULT1E1 | CA2 1137/4885CA1 2532/4885CA9 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.